quantisnow
FeedTopReportsPricing
⌘K
Live feed
15:30:00·38d
INSIDERFiling
NeuroOne Medical Technologies Corporation logo

Business Development Director Christianson Mark sold $734 worth of shares (917 units at $0.80), decreasing direct ownership by 0.43% to 214,283 units (SEC Form 4)

NMTC· NeuroOne Medical Technologies Corporation
Health Care
Original source

Companies

  • NMTC
    NeuroOne Medical Technologies Corporation
    Health Care

Recent analyst ratings

  • May 5UpdateLadenburg Thalmann$1.45
  • Mar 29UpdateCraig Hallum$2.00
  • Dec 3UpdateAlliance Global Partners$5.75
  • Nov 15UpdateCraig-Hallum$6.00

Related

  • SEC2d
    SEC Form SCHEDULE 13G filed by NeuroOne Medical Technologies Corporation
  • SEC10d
    NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
  • INSIDER16d
    SEC Form 4 filed by Mills Jason Richard
  • INSIDER16d
    SEC Form 4 filed by Mathiesen Jeffrey S
  • INSIDER16d
    SEC Form 4 filed by Buckman Paul
  • INSIDER16d
    SEC Form 4 filed by Andrle Edward
  • SEC20d
    NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
  • INSIDER22d
    SEC Form 4 filed by Christianson Mark
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022